BETH ISRAEL DEACONESS MEDICAL CENTER
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1896-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.bidmc.org/
The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery
- First Posted Date
- 2018-12-03
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT03762109
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Temporal Interference Brain Stimulation
Not Applicable
Terminated
- Conditions
- Visual Acuity
- Interventions
- Device: Temporal Interference (TI) Stimulation
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 8
- Registration Number
- NCT03747601
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Open-Label Placebo for Functional Dyspepsia
Early Phase 1
Terminated
- Conditions
- Dyspepsia
- Interventions
- Drug: Placebos
- First Posted Date
- 2018-11-19
- Last Posted Date
- 2020-05-06
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT03745781
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients
Terminated
- Conditions
- HypervolemiaCongestive Heart FailureSeptic ShockAcute Heart FailureInfectionHypovolemia
- Interventions
- Procedure: Peripheral Intravenous Analysis (PIVA)Procedure: Non-invasive fluid response measureDiagnostic Test: Passive leg raise (PLR)
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT03736421
- Locations
- πΊπΈ
St. Vincent Hospital, Worcester, Massachusetts, United States
πΊπΈBeth Israel Medical Center, Boston, Massachusetts, United States
πΊπΈUniversity of Washington, Seattle, Washington, United States
Oxygen Therapy for Retinal Ischemia
Phase 4
Withdrawn
- Conditions
- Retinal Ischemia
- Interventions
- Drug: Hyperoxia
- First Posted Date
- 2018-11-05
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT03730779
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Thiamine As Adjunctive Therapy for Diabetic Ketoacidosis
Phase 2
Completed
- Conditions
- Diabetic Ketoacidosis
- Interventions
- Drug: 200mg IV thiamine in 50mL 0.9% salineDrug: Placebo
- First Posted Date
- 2018-10-24
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03717896
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Adaptive Support Ventilation in Acute Respiratory Distress Syndrome
Not Applicable
Completed
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- Other: ASVOther: Lung Protective Ventilation
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT03715751
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Mind Body Program for Fear of Recurrence
Not Applicable
Completed
- Conditions
- Cancer Survivors
- Interventions
- Behavioral: Mind-Body Program for Fear of Recurrence
- First Posted Date
- 2018-10-04
- Last Posted Date
- 2022-02-01
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 23
- Registration Number
- NCT03695406
- Locations
- πΊπΈ
Beth Israel Deaconess Medial Center, Boston, Massachusetts, United States
The Digital Incentive Spirometer (DIS): Improving Adherence to Incentive Spirometry
Not Applicable
Completed
- Conditions
- Post-Op InfectionPulmonary AtelectasisPost-Op ComplicationAdherence, PatientIncentive Spirometry
- Interventions
- Behavioral: Smartphone Arm
- First Posted Date
- 2018-09-27
- Last Posted Date
- 2019-09-24
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT03686631
- Locations
- πΊπΈ
BIDMC, Boston, Massachusetts, United States
Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients
Phase 1
Recruiting
- Conditions
- Acute Myelogenous Leukemia
- Interventions
- Biological: DC/AML fusion cells
- First Posted Date
- 2018-09-20
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT03679650
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
πΊπΈDana Farber Cancer Institute, Boston, Massachusetts, United States